. 2004 Nov 29;76(1):82–90. doi: 10.1086/427224

Table 3.

OR, 95% CI, and P Value for the Minor Allele of Each AR SNP and Risk of Prostate Cancer (All Racial/Ethnic Groups Combined)^[Note]

	Findings for the Minor Allele of Each AR SNP and Risk of Prostate Cancer
	All Cases			Advanced-Stage Cases
SNP	OR^a	95% CI	P^b	OR^a	95% CI	P^b
rs6525177	.93	.61–1.42	.75	.89	.50–1.57	.69
rs12557549	2.32	.44–12.31	.32	2.49	.33–19.03	.38
rs5964602	.90	.60–1.36	.61	.85	.49–1.48	.56
rs962458	1.22	.79–1.89	.36	1.40	.80–2.46	.24
rs12007229	.75	.48–1.18	.21	.51	.26–1.01	.05
rs6152	1.15	.79–1.66	.47	1.24	.77–2.0	.37
rs1204041	.61	.36–1.03	.07	.42	.20–.90	.02
rs1204040	1.20	.80–1.79	.37	1.09	.64–1.86	.76
rs1204038	.88	.59–1.33	.55	.85	.49–1.46	.56
rs2361630	1.17	.81–1.71	.41	1.29	.79–2.12	.31
rs1926925	.58	.33–1.02	.06	.35	.15–.86	.02
rs1926926	.55	.32–.96	.04	.29	.11–.72	.01
rs1926927	.54	.31–.95	.03	.33	.14–.81	.01
rs2361634	.62	.26–1.48	.28	1.09	.39–3.0	.88
rs2361636	.46	.25–.86	.01	.28	.10–.75	.01
rs1361039	1.35	.29–6.39	.70	2.26	.35–14.48	.39
rs1337077	.63	.36–1.10	.11	.41	.18–.96	.04
rs1337078	.58	.33–1.02	.06	.40	.17–.92	.03
rs1337079	.57	.32–.99	.05	.34	.14–.81	.02
rs1337080	.99	.62–1.57	.96	.83	.45–1.55	.56
rs1572500	.54	.30–.97	.04	.39	.16–.96	.04
ARa15	4.63	.47–45.9	.19	6.18	.52–74.03	.15
rs1337075	.56	.31–1.02	.06	.34	.13–.86	.02
rs1572501	3.19	.66–15.42	.15	.87	.08–10.13	.91
rs1361038	1.12	.57–2.19	.75	.85	.34–2.11	.73
rs1337076	1.07	.63–1.82	.81	.88	.44–1.78	.73
rs10060	1.01	.63–1.63	.97	.96	.52–1.78	.89
rs1337082	.96	.65–1.41	.84	.90	.54–1.49	.68
rs945052	.98	.59–1.61	.93	.85	.44–1.64	.62
rs945048	.94	.57–1.54	.80	.77	.39–1.50	.43
rs945050	.87	.61–1.25	.45	.81	.51–1.31	.40
rs1361037	1.10	.67–1.83	.71	.89	.45–1.76	.74

Note.— All 32 SNPs across the AR are individually tested for association with prostate cancer in the entire MEC population.

Adjusted for age and race/ethnicity.

P values are two-sided, with no correction for multiple testing.